\-\ Texto\\:\\ \ \(0\)\
\-\ overweight\\ white\\ man\\.\\ \\ no\\ masses\\ on\\ abdominal\\ exam\\.\ \(0\)\
\-\ esophageal\\ stent\\,\\ expectant\\ management\ \(0\)\
\-\ upper\\ gi\\ fluoroscopy\\ \\-\\ shows\\ a\\ polypoid\\,\\ ulcerated\\ distal\\ esophageal\\ mass\\,\\ with\\ inflammatory\\ changes\\ vs\\.\\ superficial\\ spread\\ into\\ the\\ adjacent\\ gastric\\ fundus\\.\ \(0\)\
\-\ ct\\ shows\\ multiple\\ rounded\\ lesions\\ in\\ the\\ liver\ \(0\)\
\-\ adenocarcinoma\\ of\\ the\\ esophagus\ \(0\)\
\-\ esophageal\\ adenocarcinoma\\ metastatic\\ to\\ liver\ \(0\)\
\-\ esophageal\\ squamous\\ carcinoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 64\\ yo\\ gentleman\\ who\\ presents\\ with\\ 6\\ months\\ of\\ dysphagia\\ to\\ solids\\.\\ \\ he\\ did\\ smoke\\,\\ but\\ quit\\ 20\\ yrs\\ ago\\.\\ \\ he\\ denies\\ more\\ than\\ social\\ drinking\\.\\ \\ admits\\ to\\ occasional\\ esophageal\\ reflux\\.\ \(0\)\
\-\ adenocarcinoma\\ is\\ increasing\\ in\\ frequency\\.\\ \\ dysphagia\\ should\\ be\\ evaluated\\ with\\ an\\ upper\\ gi\\,\\ which\\ is\\ an\\ easily\\ performed\\ test\\.\\ \\ \ \(0\)\
\-\ esophageal\\ carcinoma\\ spreads\\ fairly\\ quickly\\ as\\ the\\ esophagus\\ does\\ not\\ have\\ a\\ serosal\\ membrane\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ esophageal\\:\\ 0\\.170333853218069\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.08025118357746172\ \(0\)\
\-\ spreads\\:\\ 0\\.0638805682896123\ \(0\)\
\-\ dysphagia\\:\\ 0\\.06031243585230399\ \(0\)\
\-\ gi\\:\\ 0\\.05563456060211484\ \(0\)\
\-\ esophagus\\:\\ 0\\.05376192681254953\ \(0\)\
\-\ serosal\\:\\ 0\\.05221797472124926\ \(0\)\
\-\ expectant\\:\\ 0\\.05089680401984379\ \(0\)\
\-\ drinking\\:\\ 0\\.05089680401984379\ \(0\)\
\-\ overweight\\:\\ 0\\.04795865106253825\ \(0\)\
\-\ ulcerated\\:\\ 0\\.0458739983636123\ \(0\)\
\-\ smoke\\:\\ 0\\.0458739983636123\ \(0\)\
\-\ quit\\:\\ 0\\.0458739983636123\ \(0\)\
\-\ admits\\:\\ 0\\.0458739983636123\ \(0\)\
\-\ gentleman\\:\\ 0\\.043789345664686355\ \(0\)\
\-\ solids\\:\\ 0\\.042935845406306766\ \(0\)\
\-\ liver\\:\\ 0\\.042698862475836576\ \(0\)\
\-\ polypoid\\:\\ 0\\.04217236340878628\ \(0\)\
\-\ quickly\\:\\ 0\\.04181881149451504\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.040851192707380815\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.039479873869420465\ \(0\)\
\-\ yrs\\:\\ 0\\.03923421045148074\ \(0\)\
\-\ fairly\\:\\ 0\\.03629605749417521\ \(0\)\
\-\ membrane\\:\\ 0\\.03629605749417521\ \(0\)\
\-\ social\\:\\ 0\\.03613679005418408\ \(0\)\
\-\ fundus\\:\\ 0\\.03582838705114933\ \(0\)\
\-\ carcinoma\\:\\ 0\\.035100401014722706\ \(0\)\
\-\ stent\\:\\ 0\\.03484192201981179\ \(0\)\
\-\ he\\:\\ 0\\.034553439739608977\ \(0\)\
\-\ easily\\:\\ 0\\.03421140479524926\ \(0\)\
\-\ shows\\:\\ 0\\.03404889419896926\ \(0\)\
\-\ 64\\:\\ 0\\.03374373435222338\ \(0\)\
\-\ superficial\\:\\ 0\\.03309437088345753\ \(0\)\
\-\ occasional\\:\\ 0\\.032691690802625566\ \(0\)\
\-\ frequency\\:\\ 0\\.032691690802625566\ \(0\)\
\-\ metastatic\\:\\ 0\\.031175498603131742\ \(0\)\
\-\ rounded\\:\\ 0\\.030509769840423237\ \(0\)\
\-\ squamous\\:\\ 0\\.03029557562128161\ \(0\)\
\-\ spread\\:\\ 0\\.029952081136538248\ \(0\)\
\-\ upper\\:\\ 0\\.029885224715488674\ \(0\)\
\-\ reflux\\:\\ 0\\.02860857951819504\ \(0\)\
\-\ evaluated\\:\\ 0\\.028388975536344833\ \(0\)\
\-\ gastric\\:\\ 0\\.02766888514639408\ \(0\)\
\-\ test\\:\\ 0\\.026454582971325972\ \(0\)\
\-\ denies\\:\\ 0\\.026130668631341142\ \(0\)\
\-\ increasing\\:\\ 0\\.025379075687860225\ \(0\)\
\-\ vs\\:\\ 0\\.02438028964058549\ \(0\)\
\-\ management\\:\\ 0\\.023366169880113342\ \(0\)\
\-\ ago\\:\\ 0\\.023048759570994556\ \(0\)\
\-\ did\\:\\ 0\\.022358106094151623\ \(0\)\
\-\ 20\\:\\ 0\\.022264603160558085\ \(0\)\
\-\ inflammatory\\:\\ 0\\.021473303943420462\ \(0\)\
\-\ does\\:\\ 0\\.021127688915826132\ \(0\)\
\-\ masses\\:\\ 0\\.020931828970986138\ \(0\)\
\-\ white\\:\\ 0\\.02053698704863781\ \(0\)\
\-\ should\\:\\ 0\\.019740641607889856\ \(0\)\
\-\ adjacent\\:\\ 0\\.019578523508219328\ \(0\)\
\-\ yo\\:\\ 0\\.018632982052918565\ \(0\)\
\-\ 6\\:\\ 0\\.018493624357788944\ \(0\)\
\-\ changes\\:\\ 0\\.017746724465471455\ \(0\)\
\-\ lymphoma\\:\\ 0\\.017697091553546998\ \(0\)\
\-\ performed\\:\\ 0\\.017265060371212455\ \(0\)\
\-\ an\\:\\ 0\\.017125577743256955\ \(0\)\
\-\ months\\:\\ 0\\.016912618077464255\ \(0\)\
\-\ distal\\:\\ 0\\.01683535209381179\ \(0\)\
\-\ lesions\\:\\ 0\\.016576525408289477\ \(0\)\
\-\ than\\:\\ 0\\.016224991702306332\ \(0\)\
\-\ who\\:\\ 0\\.016144698616968857\ \(0\)\
\-\ more\\:\\ 0\\.015486784850088161\ \(0\)\
\-\ abdominal\\:\\ 0\\.015477675638566052\ \(0\)\
\-\ into\\:\\ 0\\.014734249043186282\ \(0\)\
\-\ man\\:\\ 0\\.014644433645579704\ \(0\)\
\-\ exam\\:\\ 0\\.013603144492387958\ \(0\)\
\-\ have\\:\\ 0\\.013408971582355737\ \(0\)\
\-\ \\-\\:\\ 0\\.013273394628321476\ \(0\)\
\-\ but\\:\\ 0\\.013206545659663317\ \(0\)\
\-\ multiple\\:\\ 0\\.013042072488980209\ \(0\)\
\-\ presents\\:\\ 0\\.012649596344260333\ \(0\)\
\-\ which\\:\\ 0\\.011559018748134411\ \(0\)\
\-\ disease\\:\\ 0\\.010121286530548581\ \(0\)\
\-\ \\,\\:\\ 0\\.009808335707148093\ \(0\)\
\-\ be\\:\\ 0\\.009548961763361806\ \(0\)\
\-\ as\\:\\ 0\\.009366503665899476\ \(0\)\
\-\ to\\:\\ 0\\.009284089313977962\ \(0\)\
\-\ not\\:\\ 0\\.008947961389434314\ \(0\)\
\-\ ct\\:\\ 0\\.008661620676753934\ \(0\)\
\-\ mass\\:\\ 0\\.008612036282228728\ \(0\)\
\-\ is\\:\\ 0\\.008149141715720662\ \(0\)\
\-\ no\\:\\ 0\\.006235102541331899\ \(0\)\
\-\ in\\:\\ 0\\.006107206233916738\ \(0\)\
\-\ a\\:\\ 0\\.005747823214762337\ \(0\)\
\-\ on\\:\\ 0\\.005245587046126291\ \(0\)\
\-\ the\\:\\ 0\\.004007225643583356\ \(0\)\
\-\ \\.\\:\\ 0\\.0028296731671797752\ \(0\)\
\-\ with\\:\\ 0\\.0025435690454323856\ \(0\)\
\-\ of\\:\\ 0\\.0016884608811302672\ \(0\)\
